Navamedic launches mosquito repellent brand in Denmark
Oslo, 29 March 2016 - Navamedic ASA (OSE: NAVA), the Norwegian medtech and pharmaceutical products company, today announced that the company is expanding its portfolio of over-the-counter (OTC) products in Denmark with the launch of its own mosquito repellent brand, Mygfri®, at Danish pharmacies all across the country. The newly introduced product is the first and only in its class in Denmark.
Navamedic enters into agreement with Pennine Healthcare as distributor for Sippi® in the UK
Navamedic ASA (OSE: NAVA), the Norwegian Medtech and pharmaceutical products company, announced today that an agreement has been signed with UK-based Pennine Healthcare, a leading distributor and manufacturer of sterile medical devices, for the launch of Sippi® in Great Britain, Ireland and Northern Ireland.
Navamedic expands cooperation with Pohl-Boskamp
Oslo, 3 March 2016 - Navamedic ASA (OSE: NAVA) the Norwegian medtech and pharmaceutical marketing- and distribution company today announced an expanded cooperation agreement with German pharmaceutical manufacturer, Pohl-Boskamp, for distribution of Nitrolingual® Pumpspray in the Nordic markets.